Â鶹ƵµÀ

Krebsforschung

We are an enthusiastic, international team of researchers who conduct targeted translational research in the field of oncology.

Spokesperson of the research field

Amin El-Heliebi 
T: +43 316 385 71903
Amin El-Heliebi

Vice spokesperson of the research field

Michael Dengler  
T: +43 316 385 31428
Michael Dengler

Executive committee

Members

Preclinical research

Vorklinische Forschung
Vorklinische Forschung

Clinical research

Klinische Forschung
  • ("tumor microenvironment" in lymphoma with a focus on tumor immunology)
  • (molecular leukemogenesis and genome engineering)
  • (genetic epidemiology and pharmacogenetics)
  • Research team of Armin Zebisch (inflammation, autoimmunity and cancer)
  • Research team of Georg Hutterer (outcomes research on uro-oncological tumor entities)
  • Research team of Heinz Sill (myeloid cells and leukemia)
  • (translational breast cancer research)
Klinische Forschung
  • Research team of Martin Pichler (non-coding RNAs and genome editing in cancer)
  • Research team of Michael Dengler (identifying novel cancer drivers and drug resistance mechanisms using CRISPR)
  • Research team of Nadia Dandachi (epigenetic and genetic tumor biomarkers)
  • (molecular basis of the development of lymphatic neoplasia)
  • (molecular oncology)
  • Research team of Sebastian Vosberg (translational bioinformatics in cancer research)
  • (ion channels)
Labor

Interdisciplinary translational research in sarcoma

  • Research team of Bernadette Liegl-Atzwanger (translational sarcoma pathology)
  • Research team of Joanna Szkandera (translational sarcoma oncology)
  • Research team of Jasminka Igrec (translational radiology)
  • Research team of Andreas Leithner (tumor orthopedics)
  • (pediatric hematology/oncology)